1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. ARTEMIS MEDICARE SERVICES LTD.
Artemis Medicare Services Ltd.
NSE: ARTEMISMED | BSE: 542919

Artemis Medicare Serv Live Share Price Today, Share Analysis and Chart

aboutArtemis Medicare Services Ltd. (Artemis) is a tertiary care healthcare provider established in 2007 by the promoters of the Apollo Tyres Group. The company operates its flagship facility, Artemis Hospital, in Gurugram, India, which is a multi-special... Read More
Occupancy RateARPOB (Rev per Bed)
Ask AI about Artemis Medicare Serv
293.20-4.75(-1.59%)
175.6K
NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Mid-range PerformerThese stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investorsView SimilarEmbed DVM

Artemis Medicare Serv Stock Price Analysis

Day Price Range

-1.6% 1 Day return
293.2 (LTP)
287.7302.2
LowHigh

Week Price Range

2.9% 1 Week return
293.2 (LTP)
276304.1
LowHigh

Month Price Range

-20.0% 1 Month return
293.2 (LTP)
276370.1
LowHigh

52 Week Price Range

16.1% 1 Year return
293.2 (LTP)
203.4378.8
LowHigh

Artemis Medicare Serv Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

EPS forecast

CURRENT EPS
6.6
AVG. ESTIMATE
8.3
LOW ESTIMATE
7.4
HIGH ESTIMATE
8.7
CURRENT EPS
AVG. ESTIMATE

Consensus Recommendation

5 ANALYST Recommendations
STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Artemis Medicare Serv Technical Analysis

Artemis Medicare Serv EMA & SMA

Bearish-6
1 bullish, 7 bearish
Bullish1
Bearish7
5 Day295.8
10 Day298.5
12 Day300.1
20 Day306.1
26 Day309.3
50 Day312.2
100 Day302.8
200 Day286.3

Artemis Medicare Serv Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202641.2%
Week48.3%
Month51.9%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Artemis Medicare Serv Resistance and Support

294.35
Pivot
First Resistance301
Second Resistance308.8
Third Resistance315.5
First Support286.6
Second Support279.9
Third Support272.1
Day RSI38.6
Day MACD-9.2
Day MFI24.6
Day MACD Signal Line-8.5

Artemis Medicare Serv Beta

1 Month1.0
1 Year0.8
3 Month0.8
3 Year0.9

Artemis Medicare Serv Price Change Analysis

↓-20.0%
Over 1 Month
LowHigh
276370.1
↓-3.0%
Over 3 Months
LowHigh
276378.8
↑22.2%
Over 6 Months
LowHigh
237.8378.8
↑16.1%
Over 1 Year
LowHigh
203.4378.8

Artemis Medicare Serv Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Constructive Finance Private LimitedPromoter92,425,79058.4 %
International Finance CorporationFii18,962,24712.0 %
Devlina ChakravartyPublic4,490,2642.8 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Artemis Medicare Serv Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
MICROCURVES TRADING PRIVATE LIMITEDBulkSell25 Sep 2026366.151,004,061NSE
MICROCURVES TRADING PRIVATE LIMITEDBulkPurchase25 Sep 2026365.801,004,061NSE

Artemis Medicare Serv Corporate Actions

Artemis Medicare Serv Dividend history and yield

Artemis Medicare Serv dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Artemis Medicare Serv dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
110 Jul 2026
0.45FINAL10 Jul 2026Equity Share
211 Jul 2025
0.45FINAL11 Jul 2025Equity Share
305 Jul 2024
0.45FINAL05 Jul 2024Equity Share
414 Jul 2023
0.45FINAL14 Jul 2023Equity Share

Artemis Medicare Serv Board Meetings

Artemis Medicare Serv past and upcoming board meetings.

#Ex-Date
PurposeNotes
130 Oct 2026
Quarterly Results-
203 Aug 2026
Quarterly Results-
304 Jun 2026
OthersTo consider Other business matters.
408 May 2026
Audited Results & Final Dividend-
502 Feb 2026
Quarterly Results & Others-

Artemis Medicare Serv Stock Split

Artemis Medicare Serv stock split details, including announcement, record, and ex-split dates, along with the split ratios

#Ex-Date
Old FVNew FVRecord Date
123 Sep 2021
10124 Sep 2021

Artemis Medicare Serv Research Reports

Artemis Medicare Serv research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
109 Sep 2026ICICI Direct
Target
410348.55Buy17.63%-15.88%pdf
224 May 2026ICICI Direct340287.92Buy18.09%1.83%pdf
310 May 2026ICICI Direct340281.12Buy20.94%4.3%pdf
404 Apr 2023Ventura13468.1Buy96.77%330.54%pdf

Artemis Medicare Serv Corporate Filings

Artemis Medicare Serv BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
31 Oct 2026
Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - October 31, 2026
PDF
30 Oct 2026
Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for the quarter ended September 30, 2026
PDF
30 Oct 2026
Q2FY27 Quarterly Result Announced for Artemis Medicare Services Ltd.
Healthcare Facilities company Artemis Medicare Services announced Q2FY27 results Consolidated Financial Highlights: Revenue from Operations: Rs 31,104.14 lakh in Q2FY27, indicating an increase of 8.25% QoQ from Rs 28,732.35 lakh in Q1FY27 and an increase of 13.23% YoY from Rs 27,470.28 lakh in Q2FY26. For H1FY27, Revenue from Operations stood at Rs 59,836.49 lakh, up 12.97% YoY from Rs 52,966.37 lakh in H1FY26. Total Income: Rs 31,911.72 lakh in Q2FY27, reflecting an increase of 9.03% QoQ compared to Rs 29,269.74 lakh in Q1FY27 and an increase of 13.02% YoY compared to Rs 28,235.72 lakh in Q2FY26. For H1FY27, Total Income reached Rs 61,181.46 lakh, showing a YoY growth of 12.42% from Rs 54,424.60 lakh in H1FY26. Profit Before Tax (PBT): Rs 4,097.61 lakh in Q2FY27, showing a decline of 3.88% QoQ from Rs 4,263.04 lakh in Q1FY27 and an increase of 4.06% YoY from Rs 3,937.58 lakh in Q2FY26. For H1FY27, PBT registered at Rs 8,360.64 lakh, growing 20.89% YoY against Rs 6,916.02 lakh in H1FY26. Net Profit After Tax (PAT): Rs 3,109.95 lakh in Q2FY27, down 1.09% QoQ from Rs 3,144.27 lakh in Q1FY27 but up 3.66% YoY from Rs 3,000.22 lakh in Q2FY26. For H1FY27, PAT stood at Rs 6,254.22 lakh, gaining 22.15% YoY against Rs 5,119.97 lakh in H1FY26. Earning per Equity Share (EPS) - Basic: Rs 1.96 in Q2FY27, dropping 1.01% QoQ from Rs 1.98 in Q1FY27 and increasing 3.16% YoY from Rs 1.90 in Q2FY26. For H1FY27, Basic EPS stood at Rs 3.94, increasing 21.23% YoY from Rs 3.25 in H1FY26. Earning per Equity Share (EPS) - Diluted: Rs 1.96 in Q2FY27, down 1.01% QoQ from Rs 1.98 in Q1FY27 and up 3.16% YoY from Rs 1.89 in Q2FY26. For H1FY27, Diluted EPS was Rs 3.94, rising 21.60% YoY from Rs 3.24 in H1FY26. Standalone Financial Highlights: Revenue from Operations: Rs 30,570.62 lakh in Q2FY27, demonstrating a growth of 8.40% QoQ from Rs 28,200.97 lakh in Q1FY27 and a growth of 13.32% YoY from Rs 26,978.31 lakh in Q2FY26. For H1FY27, Revenue from Operations recorded at Rs 58,771.59 lakh, growing 13.11% YoY compared to Rs 51,958.17 lakh in H1FY26. Total Income: Rs 31,388.56 lakh in Q2FY27, reflecting an increase of 9.21% QoQ against Rs 28,740.55 lakh in Q1FY27 and a rise of 13.08% YoY against Rs 27,756.66 lakh in Q2FY26. For H1FY27, Total Income was Rs 60,129.11 lakh, rising 12.53% YoY from Rs 53,432.28 lakh in H1FY26. Profit Before Tax (PBT): Rs 4,076.28 lakh in Q2FY27, marking a decrease of 3.20% QoQ from Rs 4,210.98 lakh in Q1FY27 and an expansion of 2.50% YoY from Rs 3,976.87 lakh in Q2FY26. For H1FY27, PBT stood at Rs 8,287.26 lakh, increasing 18.67% YoY from Rs 6,983.58 lakh in H1FY26. Net Profit After Tax (PAT): Rs 3,095.31 lakh in Q2FY27, lower by 0.32% QoQ from Rs 3,105.11 lakh in Q1FY27 and higher by 3.30% YoY from Rs 2,996.45 lakh in Q2FY26. For H1FY27, PAT recorded at Rs 6,200.42 lakh, growing 20.67% YoY from Rs 5,138.17 lakh in H1FY26. Earning per Equity Share (EPS) - Basic & Diluted: Both parameters stood at Rs 1.96 in Q2FY27, which is unchanged QoQ from Rs 1.96 in Q1FY27, while expanding by 3.16% YoY (Basic) and 3.70% YoY (Diluted) against the Q2FY26 figures of Rs 1.90 and Rs 1.89 respectively. For H1FY27, Basic and Diluted EPS reached Rs 3.92, increasing 20.25% YoY (Basic) and 20.62% YoY (Diluted) compared to Rs 3.26 and Rs 3.25 in H1FY26. Business Highlights: Geographical Performance Breakdown: Domestic operations inside India recorded a revenue from operations of Rs 22,226.93 lakh in Q2FY27 compared to Rs 21,081.83 lakh in Q1FY27 and Rs 19,221.56 lakh in Q2FY26. For H1FY27, geographical revenue from India stood at Rs 43,308.76 lakh compared to Rs 37,674.43 lakh in H1FY26. Operations outside India registered a revenue from operations of Rs 8,811.21 lakh in Q2FY27 compared to Rs 7,650.52 lakh in Q1FY27 and Rs 8,248.12 lakh in Q2FY26. For H1FY27, geographical revenue from outside India stood at Rs 16,521.13 lakh compared to Rs 15,291.94 lakh in H1FY26. Onkar Kanwar, Chairman, Artemis Medicare Services, said: “We have delivered a steady performance in the second quarter of FY27, with consolidated revenue growing 13.0% YoY. This reflects the resilience of our business model, sustained demand for quality healthcare services, and our continued focus on disciplined execution. The commencement of operations at our Raipur hospital in July 2026 marks an important milestone in Artemis’ growth journey, expanding our presence into new markets and extending access to advanced healthcare services beyond our established Gurugram centre. As we build out our healthcare platform, we remain committed to a calibrated approach to expansion, with a focus on clinical excellence, operational sustainability, and prudent capital allocation. Looking ahead, we will continue to strengthen our core operations while progressing our strategic expansion plans. With a clear long-term vision and an unwavering commitment to quality healthcare, we remain focused on building a resilient healthcare platform that creates sustainable value for our patients, employees, stakeholders, and shareholders.” Devlina Chakravarty, Managing Director, Artemis Medicare Services, said: “The second quarter of FY27 reflects continued momentum in our core Gurugram operations, supported by healthy revenue growth, improved occupancy, and stronger operating profitability. The hospital recorded year-on-year revenue growth of 14.5%, while Ops. EBITDA and PAT grew by 26.3% and 25.9%, respectively. Improved bed occupancy of 68.1% and higher average revenue per occupied bed further demonstrate the strength of our operating performance and the sustained demand for our specialised clinical services. At the consolidated level, revenue from operations grew 13.2% YoY, while Adjusted EBITDA* increased by 22.7%, reflecting underlying operating progress. Our priorities remain centred on enhancing operational efficiencies, maintaining disciplined cost management, strengthening clinical capabilities, and delivering consistently high standards of patient care. With the commencement of operations at our Raipur hospital in July 2026, we have entered an important new phase of expansion. Our focus is now on progressively building clinical capabilities, expanding specialised services, and establishing the facility as a trusted destination for advanced healthcare in Central India. Going forward, we will continue to strengthen our existing operations and pursue measured expansion, with the objective of building a future-ready healthcare platform that delivers superior clinical outcomes and sustainable long-term value for all our stakeholders.” Result PDF
PDF
30 Oct 2026
Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation
Earnings Presentation - Q2 and H1 FY27
PDF
30 Oct 2026
Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - October 30, 2026
PDF

Artemis Medicare Serv DocumentsAsk MarketMind AI

Artemis Medicare Serv Earnings Call

Artemis Medicare Serv earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
10 Aug 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
04 Aug 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
15 May 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
11 May 2026Artemis Medicare Services Results Earnings Call for Q4FY26 & Full Year
09 Feb 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Artemis Medicare Serv Annual Reports

Artemis Medicare Serv financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026
2025Annual Report Mar-2025
2024Annual Report Mar-2024
2023Annual Report Mar-2023
2022Annual Report Mar-2022

Artemis Medicare Serv Credit Ratings

Artemis Medicare Serv credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
29 Sep 2026care ratingsArtemis Medicare Services Limited
11 Aug 2025care ratingsArtemis Medicare Services Limited
02 Sep 2024care ratingsArtemis Medicare Services Limited
27 Aug 2023care ratingsArtemis Medicare Services Limited

Artemis Medicare Serv Investor Presentations

Artemis Medicare Serv investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
30 Oct 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation
03 Aug 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation
08 May 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation
02 Feb 2026Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation
11 Nov 2025Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation

Artemis Medicare Serv - Company Profile

Artemis Medicare Serv Management Structure

Artemis Medicare Serv management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Sanjiv Kumar KothariChief Financial Officer-Mar 26
(Flt. Lt.) Saras MalikChief People Officer-Mar 26
Dr. Manju AggarwalChief Medical Services-Mar 26
Dr. Anjali KaulChief Medical Services(Medical)-Mar 26
Dr. Vishal AroraChief Business Officer-Mar 26
Mr. Pradeep Kumar SahaGroup Chief Information Officer-Mar 26
Mr. Rudra Narayan AcharjeeHead(Investor Relations,M&A,Growth Strategy)-Mar 26
Mr. Vivek SinghHead(Legal.)-Mar 26
POONAM MAKKARCompany Secretary,Compliance Officer-Mar 26

Artemis Medicare Serv Board of Directors

Artemis Medicare Serv Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Devlina ChakravartyExecutive Director & MD5268.59Mar 26
Sunil TandonIndependent Non Exe. Director22Mar 26
Akshay ChudasamaIndependent Non Exe. Director21.6Mar 26
Vinod RaiIndependent Non Exe. Director21.2Mar 26
Shalini Kanwar ChandNon-Exec & Non-Independent Dir21Mar 26
Neeraj KanwarNon-Exec & Non-Independent Dir20.6Mar 26
Onkar S KanwarChairman & Non Executive Dir.20Mar 26
Sunam SarkarNon-Exec & Non-Independent Dir18.92Mar 26
Pallavi ShroffIndependent Non Exe. Director18.6Mar 26
Tapan MitraIndependent Non Exe. Director-Mar 26
GIRDHAR JESSARAM GYANIIndependent Non Exe. Director-Mar 26
POONAM MAKKARCompany Sec. & Compli. Officer-Mar 26

About the company - Business Profile

Artemis Medicare Services Ltd. (Artemis) is a tertiary care healthcare provider established in 2007 by the promoters of the Apollo Tyres Group. The company operates its flagship facility, Artemis Hospital, in Gurugram, India, which is a multi-specialty institution. Artemis holds the distinction of being the first hospital in Gurugram to receive accreditation from both the Joint Commission International (JCI), USA, and the National Accreditation Board for Hospitals & Healthcare Providers (NABH).

The company provides advanced medical and surgical interventions across more than 40 medical specialties, supported by 14 centers of excellence. Its primary market position is centered in the Delhi-NCR region, though it has recently expanded its geographical footprint through new facilities in New Gurugram and international operations in Mauritius.

Key Points

  • Key Facts:
    • Founded: 2007.
    • Headquarters: Gurugram, Haryana.
    • Promoter Group: Apollo Tyres Group (Constructive Finance Pvt Ltd holds 66.5% as of September 2025).
    • Stock Listing: NSE and BSE (Stock Code: ARTEMISMED).
  • Operations and Resources:
    • Flagship Facility: 700-bed super-specialty hospital in Gurugram spread across 8.23 acres.
    • International Presence: Operates the 80-bed Artemis Curepipe Hospital in Mauritius (commenced in FY24).
    • Expansion Pipeline: Plans to reach approximately 2,000 beds by 2028. Key projects include a 300+ bed hospital in Raipur (expected April/May 2026) and a 650+ bed facility planned for South Delhi.
  • Ownership Structure (as of Sept 2025):
    • Promoters: 66.5%.
    • Government (Kerala State): ~7.1% (Governor of Kerala and KSIDC).
    • Public/Others: ~26.4% (including DIIs like HSBC Focused Fund and LIC Mutual Fund).
  • Business Model and Competencies:
    • The company operates a fee-for-service model involving inpatient (IPD) and outpatient (OPD) services.
    • It is recognized for its high clinical outcomes in complex procedures such as oncology, cardiology, and organ transplants.
    • A significant portion of its revenue is driven by international medical tourism and insured patients.
  • Revenue Breakdown (FY25 - Consolidated):
    • Total Revenue from Operations: Rs. 91,326.13 Lakhs (Standalone) / Rs. 93,691.67 Lakhs (Consolidated).
    • Geographical Split (H1 FY26):
      • India: ~68% (Rs. 32,188 Lakhs).
      • Outside India: ~32% (Rs. 15,294 Lakhs).
    • Specialty Segmentation (FY25):
      • Oncology: 20%.
      • Cardiology: 17%.
      • Neurosciences: 14%.
      • Internal Medicine: 14%.
      • Gastroenterology: 4%.
      • Liver Transplant: 3%.
      • Nephrology: 3%.
  • Technological Advancements and Services:
    • The hospital utilizes high-end medical technology for complex surgeries, recently noted for removing a 10 kg abdominal tumor and performing intricate ENT surgeries involving the brain and spine.
    • Artemis Lite: A brand launched to cater to fast-developing residential areas with focused healthcare services.
  • Human Resources:
    • The company employs over 500 doctors.
    • While specific attrition rates for FY25 are not explicitly detailed in the brief, the company has issued equity shares to its Managing Director under the Employee Stock Option Plan (ESOP) 2021 to align leadership incentives.
  • Current Strategic Initiatives:
    • Asset-Light Expansion: Focusing on Management & Operations (O&M) contracts for international and some domestic expansions.
    • Digital Transformation: Enhancing patient engagement and operational efficiency through integrated hospital management systems.

References

  1. Annual Report May 2025
  2. Investor Presentation Feb 2026
  3. Result Nov 2025
  4. Investor Presentation Nov 2025
  5. Annual Report May 2024

Artemis Medicare Serv FAQ

Artemis Medicare Serv today is trading in the red, down by 1.59% at ₹293.2.
Artemis Medicare Serv is currently trading down 1.59% on an intraday basis. In the past week the stock rose 2.9%. Stock has been down 2.96% in the past quarter and rose 16.11% in the past year. You can view this in the share price history/seasonality section.
Artemis Medicare Serv is listed on NSE with the ticker ARTEMISMED and on BSE as 542919. It's currently trading on NSE at a share price of ₹293.2 and on BSE with a share price of ₹297.1.
The market cap of Artemis Medicare Serv is ₹4,641.54 Cr. as of Oct 30, 2026.
Artemis Medicare Serv announced a FINAL dividend of 45% which equals ₹0.45 in Jul 10, 2026.The last three ex-dates for Artemis Medicare Serv were Jul 11, 2025, Jul 05, 2024 and Jul 14, 2023. To view the full dividend history of Artemis Medicare Serv click here.
Artemis Medicare Serv has never issued bonus shares, but it has issued 1 stock split since its BSE/NSE listing. The latest announcement for Artemis Medicare Serv stock split was on Sep 23, 2021 at a ratio of 10:1.
Artemis Medicare Serv reported ₹319.12 Cr. in revenue, ₹31.03 Cr. in net profit, and ₹62.89 Cr. in EBITD as of Oct 30, 2026 for Q2 FY26-27.
According to the predictions of 5 analysts, the share price prediction for Artemis Medicare Serv is ₹345.6 with an upside of 18%.
The PE ratio of Artemis Medicare Serv is 40.46 as of Oct 30, 2026.
The PB ratio of Artemis Medicare Serv is 4.8 as of Oct 30, 2026.
You can view the latest analyst reports on the Artemis Medicare Serv reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.